The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CRISPR and Cas Genes Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The CRISPR and Cas Genes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global CRISPR and Cas Genes market size is estimated to be worth US$ 2878.8 million in 2021 and is forecast to a readjusted size of USD 4894.3 million by 2028 with a CAGR of 7.9% during review period. Genome Engineering accounting for % of the CRISPR and Cas Genes global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Vector-based Cas segment is altered to a % CAGR between 2022 and 2028.
Global key companies of CRISPR and Cas Genes include Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
CRISPR and Cas Genes market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vector-based Cas
DNA-free Cas
Market segment by Application, can be divided into
Genome Engineering
Disease Models
Others
Market segment by players, this report covers
Synthego
Thermo Fisher Scientific, Inc.
GenScript
Addgene
Merck
Integrated DNA Technologies, Inc.
Transposagen Biopharmaceuticals, Inc.
OriGene Technologies, Inc.
New England Biolabs
Horizon Discovery Group Co.
Cellecta, Inc.
Agilent Technologies
Applied StemCell, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe CRISPR and Cas Genes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of CRISPR and Cas Genes, with revenue, gross margin and global market share of CRISPR and Cas Genes from 2019 to 2022.
Chapter 3, the CRISPR and Cas Genes competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and CRISPR and Cas Genes market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe CRISPR and Cas Genes research findings and conclusion, appendix and data source.
Geographical Area
Global
The CRISPR and Cas Genes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global CRISPR and Cas Genes market size is estimated to be worth US$ 2878.8 million in 2021 and is forecast to a readjusted size of USD 4894.3 million by 2028 with a CAGR of 7.9% during review period. Genome Engineering accounting for % of the CRISPR and Cas Genes global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Vector-based Cas segment is altered to a % CAGR between 2022 and 2028.
Global key companies of CRISPR and Cas Genes include Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
CRISPR and Cas Genes market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vector-based Cas
DNA-free Cas
Market segment by Application, can be divided into
Genome Engineering
Disease Models
Others
Market segment by players, this report covers
Synthego
Thermo Fisher Scientific, Inc.
GenScript
Addgene
Merck
Integrated DNA Technologies, Inc.
Transposagen Biopharmaceuticals, Inc.
OriGene Technologies, Inc.
New England Biolabs
Horizon Discovery Group Co.
Cellecta, Inc.
Agilent Technologies
Applied StemCell, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe CRISPR and Cas Genes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of CRISPR and Cas Genes, with revenue, gross margin and global market share of CRISPR and Cas Genes from 2019 to 2022.
Chapter 3, the CRISPR and Cas Genes competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and CRISPR and Cas Genes market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe CRISPR and Cas Genes research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of CRISPR and Cas Genes
1.2 Classification of CRISPR and Cas Genes by Type
1.2.1 Overview: Global CRISPR and Cas Genes Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global CRISPR and Cas Genes Revenue Market Share by Type in 2021
1.2.3 Vector-based Cas
1.2.4 DNA-free Cas
1.3 Global CRISPR and Cas Genes Market by Application
1.3.1 Overview: Global CRISPR and Cas Genes Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Genome Engineering
1.3.3 Disease Models
1.3.4 Others
1.4 Global CRISPR and Cas Genes Market Size & Forecast
1.5 Global CRISPR and Cas Genes Market Size and Forecast by Region
1.5.1 Global CRISPR and Cas Genes Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global CRISPR and Cas Genes Market Size by Region, (2017-2022)
1.5.3 North America CRISPR and Cas Genes Market Size and Prospect (2017-2028)
1.5.4 Europe CRISPR and Cas Genes Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific CRISPR and Cas Genes Market Size and Prospect (2017-2028)
1.5.6 South America CRISPR and Cas Genes Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa CRISPR and Cas Genes Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 CRISPR and Cas Genes Market Drivers
1.6.2 CRISPR and Cas Genes Market Restraints
1.6.3 CRISPR and Cas Genes Trends Analysis
2 Company Profiles
2.1 Synthego
2.1.1 Synthego Details
2.1.2 Synthego Major Business
2.1.3 Synthego CRISPR and Cas Genes Product and Solutions
2.1.4 Synthego CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Synthego Recent Developments and Future Plans
2.2 Thermo Fisher Scientific, Inc.
2.2.1 Thermo Fisher Scientific, Inc. Details
2.2.2 Thermo Fisher Scientific, Inc. Major Business
2.2.3 Thermo Fisher Scientific, Inc. CRISPR and Cas Genes Product and Solutions
2.2.4 Thermo Fisher Scientific, Inc. CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.3 GenScript
2.3.1 GenScript Details
2.3.2 GenScript Major Business
2.3.3 GenScript CRISPR and Cas Genes Product and Solutions
2.3.4 GenScript CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 GenScript Recent Developments and Future Plans
2.4 Addgene
2.4.1 Addgene Details
2.4.2 Addgene Major Business
2.4.3 Addgene CRISPR and Cas Genes Product and Solutions
2.4.4 Addgene CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Addgene Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck CRISPR and Cas Genes Product and Solutions
2.5.4 Merck CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Merck Recent Developments and Future Plans
2.6 Integrated DNA Technologies, Inc.
2.6.1 Integrated DNA Technologies, Inc. Details
2.6.2 Integrated DNA Technologies, Inc. Major Business
2.6.3 Integrated DNA Technologies, Inc. CRISPR and Cas Genes Product and Solutions
2.6.4 Integrated DNA Technologies, Inc. CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Integrated DNA Technologies, Inc. Recent Developments and Future Plans
2.7 Transposagen Biopharmaceuticals, Inc.
2.7.1 Transposagen Biopharmaceuticals, Inc. Details
2.7.2 Transposagen Biopharmaceuticals, Inc. Major Business
2.7.3 Transposagen Biopharmaceuticals, Inc. CRISPR and Cas Genes Product and Solutions
2.7.4 Transposagen Biopharmaceuticals, Inc. CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Transposagen Biopharmaceuticals, Inc. Recent Developments and Future Plans
2.8 OriGene Technologies, Inc.
2.8.1 OriGene Technologies, Inc. Details
2.8.2 OriGene Technologies, Inc. Major Business
2.8.3 OriGene Technologies, Inc. CRISPR and Cas Genes Product and Solutions
2.8.4 OriGene Technologies, Inc. CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 OriGene Technologies, Inc. Recent Developments and Future Plans
2.9 New England Biolabs
2.9.1 New England Biolabs Details
2.9.2 New England Biolabs Major Business
2.9.3 New England Biolabs CRISPR and Cas Genes Product and Solutions
2.9.4 New England Biolabs CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 New England Biolabs Recent Developments and Future Plans
2.10 Horizon Discovery Group Co.
2.10.1 Horizon Discovery Group Co. Details
2.10.2 Horizon Discovery Group Co. Major Business
2.10.3 Horizon Discovery Group Co. CRISPR and Cas Genes Product and Solutions
2.10.4 Horizon Discovery Group Co. CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Horizon Discovery Group Co. Recent Developments and Future Plans
2.11 Cellecta, Inc.
2.11.1 Cellecta, Inc. Details
2.11.2 Cellecta, Inc. Major Business
2.11.3 Cellecta, Inc. CRISPR and Cas Genes Product and Solutions
2.11.4 Cellecta, Inc. CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Cellecta, Inc. Recent Developments and Future Plans
2.12 Agilent Technologies
2.12.1 Agilent Technologies Details
2.12.2 Agilent Technologies Major Business
2.12.3 Agilent Technologies CRISPR and Cas Genes Product and Solutions
2.12.4 Agilent Technologies CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Agilent Technologies Recent Developments and Future Plans
2.13 Applied StemCell, Inc.
2.13.1 Applied StemCell, Inc. Details
2.13.2 Applied StemCell, Inc. Major Business
2.13.3 Applied StemCell, Inc. CRISPR and Cas Genes Product and Solutions
2.13.4 Applied StemCell, Inc. CRISPR and Cas Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Applied StemCell, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global CRISPR and Cas Genes Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 CRISPR and Cas Genes Players Market Share in 2021
3.2.2 Top 10 CRISPR and Cas Genes Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 CRISPR and Cas Genes Players Head Office, Products and Services Provided
3.4 CRISPR and Cas Genes Mergers & Acquisitions
3.5 CRISPR and Cas Genes New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global CRISPR and Cas Genes Revenue and Market Share by Type (2017-2022)
4.2 Global CRISPR and Cas Genes Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global CRISPR and Cas Genes Revenue Market Share by Application (2017-2022)
5.2 Global CRISPR and Cas Genes Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America CRISPR and Cas Genes Revenue by Type (2017-2028)
6.2 North America CRISPR and Cas Genes Revenue by Application (2017-2028)
6.3 North America CRISPR and Cas Genes Market Size by Country
6.3.1 North America CRISPR and Cas Genes Revenue by Country (2017-2028)
6.3.2 United States CRISPR and Cas Genes Market Size and Forecast (2017-2028)
6.3.3 Canada CRISPR and Cas Genes Market Size and Forecast (2017-2028)
6.3.4 Mexico CRISPR and Cas Genes Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe CRISPR and Cas Genes Revenue by Type (2017-2028)
7.2 Europe CRISPR and Cas Genes Revenue by Application (2017-2028)
7.3 Europe CRISPR and Cas Genes Market Size by Country
7.3.1 Europe CRISPR and Cas Genes Revenue by Country (2017-2028)
7.3.2 Germany CRISPR and Cas Genes Market Size and Forecast (2017-2028)
7.3.3 France CRISPR and Cas Genes Market Size and Forecast (2017-2028)
7.3.4 United Kingdom CRISPR and Cas Genes Market Size and Forecast (2017-2028)
7.3.5 Russia CRISPR and Cas Genes Market Size and Forecast (2017-2028)
7.3.6 Italy CRISPR and Cas Genes Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CRISPR and Cas Genes Revenue by Type (2017-2028)
8.2 Asia-Pacific CRISPR and Cas Genes Revenue by Application (2017-2028)
8.3 Asia-Pacific CRISPR and Cas Genes Market Size by Region
8.3.1 Asia-Pacific CRISPR and Cas Genes Revenue by Region (2017-2028)
8.3.2 China CRISPR and Cas Genes Market Size and Forecast (2017-2028)
8.3.3 Japan CRISPR and Cas Genes Market Size and Forecast (2017-2028)
8.3.4 South Korea CRISPR and Cas Genes Market Size and Forecast (2017-2028)
8.3.5 India CRISPR and Cas Genes Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia CRISPR and Cas Genes Market Size and Forecast (2017-2028)
8.3.7 Australia CRISPR and Cas Genes Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America CRISPR and Cas Genes Revenue by Type (2017-2028)
9.2 South America CRISPR and Cas Genes Revenue by Application (2017-2028)
9.3 South America CRISPR and Cas Genes Market Size by Country
9.3.1 South America CRISPR and Cas Genes Revenue by Country (2017-2028)
9.3.2 Brazil CRISPR and Cas Genes Market Size and Forecast (2017-2028)
9.3.3 Argentina CRISPR and Cas Genes Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CRISPR and Cas Genes Revenue by Type (2017-2028)
10.2 Middle East & Africa CRISPR and Cas Genes Revenue by Application (2017-2028)
10.3 Middle East & Africa CRISPR and Cas Genes Market Size by Country
10.3.1 Middle East & Africa CRISPR and Cas Genes Revenue by Country (2017-2028)
10.3.2 Turkey CRISPR and Cas Genes Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia CRISPR and Cas Genes Market Size and Forecast (2017-2028)
10.3.4 UAE CRISPR and Cas Genes Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global CRISPR and Cas Genes Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global CRISPR and Cas Genes Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market CRISPR and Cas Genes Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global CRISPR and Cas Genes Revenue (USD Million) by Region (2017-2022)
Table 5. Global CRISPR and Cas Genes Revenue Market Share by Region (2023-2028)
Table 6. Synthego Corporate Information, Head Office, and Major Competitors
Table 7. Synthego Major Business
Table 8. Synthego CRISPR and Cas Genes Product and Solutions
Table 9. Synthego CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific, Inc. Major Business
Table 12. Thermo Fisher Scientific, Inc. CRISPR and Cas Genes Product and Solutions
Table 13. Thermo Fisher Scientific, Inc. CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. GenScript Corporate Information, Head Office, and Major Competitors
Table 15. GenScript Major Business
Table 16. GenScript CRISPR and Cas Genes Product and Solutions
Table 17. GenScript CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Addgene Corporate Information, Head Office, and Major Competitors
Table 19. Addgene Major Business
Table 20. Addgene CRISPR and Cas Genes Product and Solutions
Table 21. Addgene CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Merck Corporate Information, Head Office, and Major Competitors
Table 23. Merck Major Business
Table 24. Merck CRISPR and Cas Genes Product and Solutions
Table 25. Merck CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Integrated DNA Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Integrated DNA Technologies, Inc. Major Business
Table 28. Integrated DNA Technologies, Inc. CRISPR and Cas Genes Product and Solutions
Table 29. Integrated DNA Technologies, Inc. CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Transposagen Biopharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Transposagen Biopharmaceuticals, Inc. Major Business
Table 32. Transposagen Biopharmaceuticals, Inc. CRISPR and Cas Genes Product and Solutions
Table 33. Transposagen Biopharmaceuticals, Inc. CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. OriGene Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. OriGene Technologies, Inc. Major Business
Table 36. OriGene Technologies, Inc. CRISPR and Cas Genes Product and Solutions
Table 37. OriGene Technologies, Inc. CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 39. New England Biolabs Major Business
Table 40. New England Biolabs CRISPR and Cas Genes Product and Solutions
Table 41. New England Biolabs CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Horizon Discovery Group Co. Corporate Information, Head Office, and Major Competitors
Table 43. Horizon Discovery Group Co. Major Business
Table 44. Horizon Discovery Group Co. CRISPR and Cas Genes Product and Solutions
Table 45. Horizon Discovery Group Co. CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Cellecta, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Cellecta, Inc. Major Business
Table 48. Cellecta, Inc. CRISPR and Cas Genes Product and Solutions
Table 49. Cellecta, Inc. CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 51. Agilent Technologies Major Business
Table 52. Agilent Technologies CRISPR and Cas Genes Product and Solutions
Table 53. Agilent Technologies CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Applied StemCell, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Applied StemCell, Inc. Major Business
Table 56. Applied StemCell, Inc. CRISPR and Cas Genes Product and Solutions
Table 57. Applied StemCell, Inc. CRISPR and Cas Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global CRISPR and Cas Genes Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global CRISPR and Cas Genes Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of CRISPR and Cas Genes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. CRISPR and Cas Genes Players Head Office, Products and Services Provided
Table 62. CRISPR and Cas Genes Mergers & Acquisitions in the Past Five Years
Table 63. CRISPR and Cas Genes New Entrants and Expansion Plans
Table 64. Global CRISPR and Cas Genes Revenue (USD Million) by Type (2017-2022)
Table 65. Global CRISPR and Cas Genes Revenue Share by Type (2017-2022)
Table 66. Global CRISPR and Cas Genes Revenue Forecast by Type (2023-2028)
Table 67. Global CRISPR and Cas Genes Revenue by Application (2017-2022)
Table 68. Global CRISPR and Cas Genes Revenue Forecast by Application (2023-2028)
Table 69. North America CRISPR and Cas Genes Revenue by Type (2017-2022) & (USD Million)
Table 70. North America CRISPR and Cas Genes Revenue by Type (2023-2028) & (USD Million)
Table 71. North America CRISPR and Cas Genes Revenue by Application (2017-2022) & (USD Million)
Table 72. North America CRISPR and Cas Genes Revenue by Application (2023-2028) & (USD Million)
Table 73. North America CRISPR and Cas Genes Revenue by Country (2017-2022) & (USD Million)
Table 74. North America CRISPR and Cas Genes Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe CRISPR and Cas Genes Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe CRISPR and Cas Genes Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe CRISPR and Cas Genes Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe CRISPR and Cas Genes Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe CRISPR and Cas Genes Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe CRISPR and Cas Genes Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific CRISPR and Cas Genes Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific CRISPR and Cas Genes Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific CRISPR and Cas Genes Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific CRISPR and Cas Genes Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific CRISPR and Cas Genes Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific CRISPR and Cas Genes Revenue by Region (2023-2028) & (USD Million)
Table 87. South America CRISPR and Cas Genes Revenue by Type (2017-2022) & (USD Million)
Table 88. South America CRISPR and Cas Genes Revenue by Type (2023-2028) & (USD Million)
Table 89. South America CRISPR and Cas Genes Revenue by Application (2017-2022) & (USD Million)
Table 90. South America CRISPR and Cas Genes Revenue by Application (2023-2028) & (USD Million)
Table 91. South America CRISPR and Cas Genes Revenue by Country (2017-2022) & (USD Million)
Table 92. South America CRISPR and Cas Genes Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa CRISPR and Cas Genes Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa CRISPR and Cas Genes Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa CRISPR and Cas Genes Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa CRISPR and Cas Genes Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa CRISPR and Cas Genes Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa CRISPR and Cas Genes Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. CRISPR and Cas Genes Picture
Figure 2. Global CRISPR and Cas Genes Revenue Market Share by Type in 2021
Figure 3. Vector-based Cas
Figure 4. DNA-free Cas
Figure 5. CRISPR and Cas Genes Revenue Market Share by Application in 2021
Figure 6. Genome Engineering Picture
Figure 7. Disease Models Picture
Figure 8. Others Picture
Figure 9. Global CRISPR and Cas Genes Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global CRISPR and Cas Genes Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global CRISPR and Cas Genes Revenue Market Share by Region (2017-2028)
Figure 12. Global CRISPR and Cas Genes Revenue Market Share by Region in 2021
Figure 13. North America CRISPR and Cas Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe CRISPR and Cas Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific CRISPR and Cas Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America CRISPR and Cas Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa CRISPR and Cas Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. CRISPR and Cas Genes Market Drivers
Figure 19. CRISPR and Cas Genes Market Restraints
Figure 20. CRISPR and Cas Genes Market Trends
Figure 21. Synthego Recent Developments and Future Plans
Figure 22. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Figure 23. GenScript Recent Developments and Future Plans
Figure 24. Addgene Recent Developments and Future Plans
Figure 25. Merck Recent Developments and Future Plans
Figure 26. Integrated DNA Technologies, Inc. Recent Developments and Future Plans
Figure 27. Transposagen Biopharmaceuticals, Inc. Recent Developments and Future Plans
Figure 28. OriGene Technologies, Inc. Recent Developments and Future Plans
Figure 29. New England Biolabs Recent Developments and Future Plans
Figure 30. Horizon Discovery Group Co. Recent Developments and Future Plans
Figure 31. Cellecta, Inc. Recent Developments and Future Plans
Figure 32. Agilent Technologies Recent Developments and Future Plans
Figure 33. Applied StemCell, Inc. Recent Developments and Future Plans
Figure 34. Global CRISPR and Cas Genes Revenue Share by Players in 2021
Figure 35. CRISPR and Cas Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players CRISPR and Cas Genes Revenue Market Share in 2021
Figure 37. Global Top 10 Players CRISPR and Cas Genes Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global CRISPR and Cas Genes Revenue Share by Type in 2021
Figure 40. Global CRISPR and Cas Genes Market Share Forecast by Type (2023-2028)
Figure 41. Global CRISPR and Cas Genes Revenue Share by Application in 2021
Figure 42. Global CRISPR and Cas Genes Market Share Forecast by Application (2023-2028)
Figure 43. North America CRISPR and Cas Genes Sales Market Share by Type (2017-2028)
Figure 44. North America CRISPR and Cas Genes Sales Market Share by Application (2017-2028)
Figure 45. North America CRISPR and Cas Genes Revenue Market Share by Country (2017-2028)
Figure 46. United States CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe CRISPR and Cas Genes Sales Market Share by Type (2017-2028)
Figure 50. Europe CRISPR and Cas Genes Sales Market Share by Application (2017-2028)
Figure 51. Europe CRISPR and Cas Genes Revenue Market Share by Country (2017-2028)
Figure 52. Germany CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific CRISPR and Cas Genes Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific CRISPR and Cas Genes Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific CRISPR and Cas Genes Revenue Market Share by Region (2017-2028)
Figure 60. China CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America CRISPR and Cas Genes Sales Market Share by Type (2017-2028)
Figure 67. South America CRISPR and Cas Genes Sales Market Share by Application (2017-2028)
Figure 68. South America CRISPR and Cas Genes Revenue Market Share by Country (2017-2028)
Figure 69. Brazil CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa CRISPR and Cas Genes Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa CRISPR and Cas Genes Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa CRISPR and Cas Genes Revenue Market Share by Country (2017-2028)
Figure 74. Turkey CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE CRISPR and Cas Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
